Literature DB >> 7684168

Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.

R Montironi1, C M Galluzzi, L Diamanti, I Giannulis, E Pisani, M Scarpelli.   

Abstract

The expression and location of proliferating cell nuclear antigen (PCNA) immunostaining in epithelial, endothelial and stromal nuclei were assessed in prostatic intra-epithelial neoplasia (PIN). It was then compared with patterns in benign lesions and in invasive adenocarcinomas of the prostate. The PCNA-positive nuclei showed homogeneous or granular types of staining, or a mixture of both, and a gradation in the intensity of staining. Nuclei with granular and mixed patterns appeared lighter brown than those with a homogeneous pattern, which are darker and more often noted in PIN and invasive adenocarcinomas than in benign lesions. For epithelial PCNA-stained nuclei, the proportions in the two grades of PIN were greater than in benign prostatic hyperplasia (mean 3.16%, SE 0.31%) and prostatic atrophic ducts and acini (mean 0.56%, SE 0.09%), the values decreasing from the nuclei in the basal position towards those in the luminal layer. In grade 1, the category mean values were 9.51% (SE 1.14%) in the basal, 7.02% (SE 1.27%) in the intermediate and 6.02% (SE 0.90%) in the luminal position. In grade 2, the category mean values were 13.81% (SE 1.42%) in the basal position, 10.99% (SE 1.17%) in the intermediate and 7.91% (SE 1.43%) in the luminal position. In small and large acinar adenocarcinomas, the proportions of positive nuclei were 8.66% (SE 0.30%) and 9.06% (SE 0.30%), respectively. The category mean values in the cribriform adenocarcinomas were 14.40% (SE 0.61%) in the basal position, 11.84% (SE 1.30%) in the intermediate and 9.26% (SE 0.66%) in the luminal position. As in PIN, the proportions of immunostained nuclei in the adenocarcinoma with cribriform pattern decreased from the basal towards the luminal layer. In the solid/trabecular adenocarcinomas, the category mean value in the cell layer adjacent to the stroma was 17.60% (SE 2.92%), whereas in the other cell layers it was lower than that in the cells adjacent the stroma (mean 13.88%, SE 1.71%). For capillary endothelial and stromal cells, the percentages of PCNA-stained nuclei were much lower than those in the epithelial component. The lowest mean values were obtained in benign lesions, whereas the highest were in invasive adenocarcinomas, the percentages in PIN being intermediate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684168     DOI: 10.1007/bf01621801

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  31 in total

Review 1.  Clinical application of morphologic and immunocytochemical assessments of cell proliferation.

Authors:  M D Linden; F X Torres; J Kubus; R J Zarbo
Journal:  Am J Clin Pathol       Date:  1992-05       Impact factor: 2.493

2.  Normal histology of the prostate.

Authors:  J E McNeal
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

3.  Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.

Authors:  H Takahashi; G M Strutton; P G Parsons
Journal:  Histopathology       Date:  1991-03       Impact factor: 5.087

4.  Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps.

Authors:  R G Wilson; A N Smith; C C Bird
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

5.  Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells.

Authors:  M Derenzini; A Pession; D Trerè
Journal:  Lab Invest       Date:  1990-07       Impact factor: 5.662

6.  The present status of radical prostatectomy for stages A and B prostatic cancer.

Authors:  H J Jewett
Journal:  Urol Clin North Am       Date:  1975-02       Impact factor: 2.241

7.  Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections.

Authors:  R Montironi; C M Galluzzi; L Diamanti; R Taborro; M Scarpelli; E Pisani
Journal:  Pathol Res Pract       Date:  1993-06       Impact factor: 3.250

8.  Multiparametric quantitation of the progression of uterine cervix preneoplasia towards neoplasia.

Authors:  G M Mariuzzi; R Montironi; C Di Loreto; S Sisti
Journal:  Pathol Res Pract       Date:  1989-11       Impact factor: 3.250

9.  Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease.

Authors:  B Helpap
Journal:  Histopathology       Date:  1988-08       Impact factor: 5.087

10.  Tumor angiogenesis. Rapid induction of endothelial mitoses demonstrated by autoradiography.

Authors:  T Cavallo; R Sade; J Folkman; R S Cotran
Journal:  J Cell Biol       Date:  1972-08       Impact factor: 10.539

View more
  9 in total

1.  Ki-67 expression in early prostate cancer and associated pathological lesions.

Authors:  M R Feneley; M P Young; C Chinyama; R S Kirby; M C Parkinson
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

2.  Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.

Authors:  Y Yang; J Hao; X Liu; B Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  Precursor lesions for prostate cancer.

Authors:  M R Feneley; C Busch
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

4.  Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer.

Authors:  Z Kolár; P G Murray; K Scott; A Harrison; B Vojtĕsek; J Dusek
Journal:  Mol Pathol       Date:  2000-02

5.  Molecular pathogenesis of human prostate basal cell hyperplasia.

Authors:  Gervaise Henry; Alicia Malewska; Ryan Mauck; Jeffrey Gahan; Ryan Hutchinson; Jose Torrealba; Franto Francis; Claus Roehrborn; Douglas Strand
Journal:  Prostate       Date:  2017-08-10       Impact factor: 4.104

Review 6.  The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.

Authors:  B G Helpap; D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.

Authors:  V Padmanabhan; P Callas; G Philips; T D Trainer; B G Beatty
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

8.  Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.

Authors:  R Montironi; C Magi Galluzzi; M Scarpelli; I Giannulis; L Diamanti
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.

Authors:  R Montironi; C Magi-Galluzzi; G Muzzonigro; E Prete; M Polito; G Fabris
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.